Project Description

Asking Price:
Listing Code:

$52 Million Specialty Pharmacy located in Missouri – MORX1A

Under LOI

American HealthCare Capital is pleased to present a dual-accredited (URAC and ACHC), independent, specialty pharmacy located in Missouri. The company has been in business since 2011 and maintains licenses in all 50 states. The Pharmacy has quickly grown to be a trusted and top provider of specialty drugs to the entire Midwest region of the United States, with the majority of their services focused on Gastroenterology, Rheumatology, and Dermatology therapies.

The pharmacy has a payor mix of 45% Medicare Part D and 55% Commercial Insurance. They fill an average of 800 prescriptions per month (200 delivered) and have an average breakdown of 15% new prescriptions and 85% refills. In 2019, the Pharmacy generated $53.4 million in revenue with an adj. EBITDA of $291,840 (0.55%). In 2020, they are projecting roughly $52 million in revenue with an adj. EBITDA of $800,000 (1.55%).

There is a full complement of staff that is expected to remain on with new ownership and management is available to assist during a short transition period.

The asking price for this opportunity is $7.5 million + inventory.

If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.

Contact Us

  • This field is for validation purposes and should be left unchanged.